Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Abiomed Inc (ABMD)

347.87   11.57 (3.44%) 01-21 01:02
Open: 339.12 Pre. Close: 336.3
High: 353.49 Low: 337.84
Volume: 588,723 Market Cap: 15,720M
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 354.02 - 355.448 355.448 - 356.919
Low: 334.428 - 335.87 335.87 - 337.357
Close: 345.459 - 348.012 348.012 - 350.643

Technical analysis

as of: 2021-01-20 4:43:58 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 412.88     One year: 482.24
Support: Support1: 295.43    Support2: 259.54
Resistance: Resistance1: 353.49    Resistance2: 412.88
Pivot: 325.52
Moving Average: MA(5): 331.18     MA(20): 320.06
MA(100): 283.33     MA(250): 241.24
MACD: MACD(12,26): 13.29     Signal(9): 12.42
Stochastic oscillator: %K(14,3): 89.06     %D(3): 81.53
RSI: RSI(14): 78.20
52-week: High: 353.49  Low: 119.01  Change(%): 88.6
Average Vol(K): 3-Month: 29719  10-Days: 35162

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ABMD has closed above the upper band by 25.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 16.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 19 Jan 2021
Abiomed, Inc. (NASDAQ:ABMD) Given Average Rating of "Hold" by Brokerages - MarketBeat

Thu, 14 Jan 2021
Abiomed Third Quarter Fiscal 2021 Earnings and Conference Call Notification - Yahoo Finance

Tue, 12 Jan 2021
Abiomed To Present At J.P. Morgan Healthcare Conference; Webcast At 5:20 PM ET - Nasdaq

Thu, 07 Jan 2021
Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1000 Patents - Business Wire

Tue, 05 Jan 2021
Is Now An Opportune Moment To Examine Abiomed, Inc. (NASDAQ:ABMD)? - Yahoo Finance

Thu, 31 Dec 2020
Andrew J. Greenfield Sells 5,000 Shares of Abiomed, Inc. (NASDAQ:ABMD) Stock - MarketBeat

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 45
Shares Float (M) 44
% Held by Insiders 2.33
% Held by Institutions 97.47
Shares Short (K) 1,930
Shares Short P. Month (K) 2,050

Stock Financials

EPS 4.550
EPS Est This Year 2.330
EPS Est Next Year 2.670
Book Value (p.s.) 26.170
Profit Margin 25.88
Operating Margin 28.09
Return on Assets (ttm) 11.5
Return on Equity (ttm) 19.1
Qtrly Rev. Growth 2.3
Gross Profit (p.s.) 15.260
Sales Per Share 17.766
EBITDA (p.s.) 5.488
Qtrly Earnings Growth 376.00
Operating Cash Flow (M) 285
Levered Free Cash Flow (M) 170

Stock Valuations

PE Ratio 76.45
PEG Ratio
Price to Book value 13.29
Price to Sales 19.58
Price to Cash Flow 55.16

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.